Meeting
2022 ASCO Genitourinary Cancers Symposium
68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high-risk prostate cancer.
Authors
Axel Heidenreich
University Hospital of Cologne, Cologne, Germany
Axel Heidenreich , Maximilian Schmautz , David A. Pfister , Florian Hartmann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 38)
DOI
10.1200/JCO.2022.40.6_suppl.038
Abstract #
38
Poster Bd #
N2
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Performance of the F-PSMA 1007 PET/CT for high-risk prostate cancer staging: Experience from a Latin American reference center.
First Author: Sebastian Peña Rodriguez
Poster
2023 ASCO Genitourinary Cancers Symposium
Detection of true positive M1 lesions by 18F-rhPSMA-7.3 PET in newly diagnosed prostate cancer: Results from the phase 3 prospective LIGHTHOUSE study.
First Author: Bridget F. Koontz
Poster
2021 Genitourinary Cancers Symposium
18F-DCFPyL PSMA PET imaging compared to conventional imaging in the detection of pelvic nodal metastases in patients with locally advanced or oligometastatic prostate cancer.
First Author: Ashanda Rosetta Patrice Esdaille
Poster
2024 ASCO Annual Meeting
Molecular and clinical correlates of high PSMA/FOLH1 mRNA expression in primary and metastatic prostate cancer (PC).
First Author: Rana R. McKay